BG33586A3 - Method for pentahydrate of cephalosporine derivative obtaining - Google Patents
Method for pentahydrate of cephalosporine derivative obtainingInfo
- Publication number
- BG33586A3 BG33586A3 BG049206A BG4920680A BG33586A3 BG 33586 A3 BG33586 A3 BG 33586A3 BG 049206 A BG049206 A BG 049206A BG 4920680 A BG4920680 A BG 4920680A BG 33586 A3 BG33586 A3 BG 33586A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- pentahydrate
- cef
- acetamide
- carboxylic acid
- derivative obtaining
- Prior art date
Links
- 150000004686 pentahydrates Chemical class 0.000 title abstract 4
- HOKIDJSKDBPKTQ-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[(5-amino-5-carboxypentanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical class S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C12 HOKIDJSKDBPKTQ-UHFFFAOYSA-N 0.000 title 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 4
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7934204 | 1979-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG33586A3 true BG33586A3 (en) | 1983-03-15 |
Family
ID=10508246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG049206A BG33586A3 (en) | 1979-10-02 | 1980-10-01 | Method for pentahydrate of cephalosporine derivative obtaining |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US4329453A (fr) |
| JP (1) | JPS5657791A (fr) |
| KR (1) | KR840001776B1 (fr) |
| AT (1) | AT368161B (fr) |
| AU (1) | AU539519B2 (fr) |
| BE (1) | BE885489A (fr) |
| BG (1) | BG33586A3 (fr) |
| CA (1) | CA1142919A (fr) |
| CH (1) | CH645118A5 (fr) |
| CS (1) | CS214721B2 (fr) |
| CY (1) | CY1338A (fr) |
| DD (1) | DD153376A5 (fr) |
| DE (1) | DE3037102C2 (fr) |
| DK (1) | DK155525C (fr) |
| EC (1) | ECSP941099A (fr) |
| ES (1) | ES8106908A1 (fr) |
| FI (1) | FI71157C (fr) |
| FR (1) | FR2466467A1 (fr) |
| GB (1) | GB2063871B (fr) |
| GR (1) | GR69123B (fr) |
| HK (1) | HK78686A (fr) |
| HU (1) | HU184835B (fr) |
| IT (1) | IT1144006B (fr) |
| KE (1) | KE3641A (fr) |
| MX (1) | MX6545E (fr) |
| MY (1) | MY8500315A (fr) |
| NL (1) | NL190329C (fr) |
| NO (1) | NO156246C (fr) |
| PL (1) | PL126606B1 (fr) |
| PT (1) | PT71860B (fr) |
| RO (1) | RO82721B (fr) |
| SE (1) | SE449614B (fr) |
| SU (1) | SU942599A3 (fr) |
| UA (1) | UA7208A1 (fr) |
| YU (1) | YU42357B (fr) |
| ZA (1) | ZA806081B (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443444A (en) * | 1980-08-11 | 1984-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4427677A (en) | 1980-12-31 | 1984-01-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4474954A (en) * | 1981-12-07 | 1984-10-02 | Bristol-Myers Company | Intermediates for cephalosporin derivatives |
| US4394503A (en) | 1981-12-07 | 1983-07-19 | Bristol-Myers Company | Cephalosporin derivatives |
| JPS58198489A (ja) * | 1982-05-14 | 1983-11-18 | Meiji Seika Kaisha Ltd | ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法 |
| ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
| DE3313818A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| DE3313816A1 (de) * | 1983-04-16 | 1984-10-18 | Hoechst Ag, 6230 Frankfurt | Neue kristallmodifikation von ceftazidim |
| GB8406218D0 (en) * | 1984-03-09 | 1984-04-11 | Glaxo Group Ltd | Process |
| US4537959A (en) * | 1984-03-26 | 1985-08-27 | Eli Lilly And Company | Crystalline cephalosporin antibiotic salt |
| JPS60231683A (ja) * | 1984-05-02 | 1985-11-18 | Teijin Ltd | セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤 |
| US4616080A (en) * | 1984-07-02 | 1986-10-07 | Eli Lilly And Company | Simplified process of forming crystalline ceftazidime pentahydrate |
| EP0169700B1 (fr) * | 1984-07-23 | 1990-05-16 | Eli Lilly And Company | Compositions pharmaceutiques de ceftazidime |
| US4626534A (en) * | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
| US4659813A (en) * | 1984-11-08 | 1987-04-21 | Eli Lilly And Company | Crystallization process for ceftazidime derivative |
| CA1239389A (fr) * | 1984-11-08 | 1988-07-19 | Melvin G. Pleiss, Jr. | Methoe de cristallisation |
| US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
| US4994451A (en) * | 1988-01-19 | 1991-02-19 | Bristol-Myers Company | Cephalosporin salts and injectable compositions |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| AT387390B (de) * | 1986-10-07 | 1989-01-10 | Biochemie Gmbh | Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy |
| US4954624A (en) * | 1986-10-07 | 1990-09-04 | Sandoz Ltd. | Process for the production of cephalosporin derivatives |
| US5021564A (en) * | 1987-02-02 | 1991-06-04 | Eli Lilly And Company | Process for preparing ceftazidime pentahydrate |
| JP2533151B2 (ja) * | 1987-02-02 | 1996-09-11 | イーライ・リリー・アンド・カンパニー | 抗生物質製造の改良法 |
| EP0321562B1 (fr) * | 1987-06-25 | 1993-11-24 | Banyu Pharmaceutical Co., Ltd. | Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes |
| WO1988010262A1 (fr) * | 1987-06-25 | 1988-12-29 | Banyu Pharmaceutical Co., Ltd. | Compose cristallin de cephalosporine |
| GB8802622D0 (en) * | 1988-02-05 | 1988-03-02 | Glaxo Group Ltd | Chemical compound |
| KR940000112B1 (ko) * | 1990-07-05 | 1994-01-05 | 주식회사 대웅제약 | 신규의 3-치환 세펨화합물 및 그의 제조방법 |
| US5831085A (en) * | 1997-01-16 | 1998-11-03 | Lupin Laboratories Limited | Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof |
| CN1328281C (zh) * | 2004-11-16 | 2007-07-25 | 广州白云山制药股份有限公司 | 头孢他啶的纯化方法 |
| CN102924483B (zh) * | 2012-10-31 | 2015-06-17 | 海南合瑞制药股份有限公司 | 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物 |
| CN102875576A (zh) * | 2012-10-31 | 2013-01-16 | 苏州致君万庆药业有限公司 | 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法 |
| CN104876949A (zh) * | 2015-05-28 | 2015-09-02 | 浙江长典医药有限公司 | 一种小儿用头孢他啶化合物实体及其制剂 |
| CN106420658A (zh) * | 2016-09-23 | 2017-02-22 | 临沂草之美医药科技有限公司 | 一种治疗外科手术感染的药物头孢他啶胶囊 |
| CN109111467A (zh) * | 2017-06-22 | 2019-01-01 | 宁应 | 一种51/4水头孢他啶化合物及其药物组合物制剂 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
-
1980
- 1980-09-09 US US06/185,883 patent/US4329453A/en not_active Expired - Lifetime
- 1980-10-01 DK DK414780A patent/DK155525C/da not_active IP Right Cessation
- 1980-10-01 SE SE8006861A patent/SE449614B/sv not_active IP Right Cessation
- 1980-10-01 ZA ZA00806081A patent/ZA806081B/xx unknown
- 1980-10-01 DD DD80224266A patent/DD153376A5/de not_active IP Right Cessation
- 1980-10-01 BE BE0/202301A patent/BE885489A/fr not_active IP Right Cessation
- 1980-10-01 PL PL1980227019A patent/PL126606B1/pl unknown
- 1980-10-01 CS CS806627A patent/CS214721B2/cs unknown
- 1980-10-01 HU HU802393A patent/HU184835B/hu unknown
- 1980-10-01 NO NO802913A patent/NO156246C/no unknown
- 1980-10-01 BG BG049206A patent/BG33586A3/xx unknown
- 1980-10-01 JP JP13822480A patent/JPS5657791A/ja active Granted
- 1980-10-01 MX MX809068U patent/MX6545E/es unknown
- 1980-10-01 FR FR8021033A patent/FR2466467A1/fr active Granted
- 1980-10-01 YU YU2497/80A patent/YU42357B/xx unknown
- 1980-10-01 DE DE3037102A patent/DE3037102C2/de not_active Expired
- 1980-10-01 PT PT71860A patent/PT71860B/pt unknown
- 1980-10-01 AT AT0490080A patent/AT368161B/de not_active IP Right Cessation
- 1980-10-01 NL NLAANVRAGE8005443,A patent/NL190329C/xx not_active IP Right Cessation
- 1980-10-01 GR GR63023A patent/GR69123B/el unknown
- 1980-10-01 CY CY1338A patent/CY1338A/xx unknown
- 1980-10-01 SU SU802987392A patent/SU942599A3/ru active
- 1980-10-01 GB GB8031703A patent/GB2063871B/en not_active Expired
- 1980-10-01 RO RO102255A patent/RO82721B/ro unknown
- 1980-10-01 CH CH734180A patent/CH645118A5/de not_active IP Right Cessation
- 1980-10-01 FI FI803126A patent/FI71157C/fi not_active IP Right Cessation
- 1980-10-01 IT IT49783/80A patent/IT1144006B/it active Protection Beyond IP Right Term
- 1980-10-01 AU AU62882/80A patent/AU539519B2/en not_active Expired
- 1980-10-01 ES ES495534A patent/ES8106908A1/es not_active Expired
- 1980-10-01 CA CA000361346A patent/CA1142919A/fr not_active Expired
- 1980-10-01 UA UA2987392A patent/UA7208A1/uk unknown
- 1980-10-02 KR KR1019800003810A patent/KR840001776B1/ko active
-
1985
- 1985-12-30 MY MY315/85A patent/MY8500315A/xx unknown
-
1986
- 1986-05-29 KE KE3641A patent/KE3641A/xx unknown
- 1986-10-16 HK HK786/86A patent/HK78686A/xx not_active IP Right Cessation
-
1994
- 1994-05-26 EC EC1994001099A patent/ECSP941099A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG33586A3 (en) | Method for pentahydrate of cephalosporine derivative obtaining | |
| IL57400A (en) | (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl-2(2-carboxyprop-2-oxyimino)acetamido)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylic acid and its derivatives,process for their preparation and pharmaceutical compositions comprising them | |
| ES458241A1 (es) | Un procedimiento para la preparacion del acido (d-alfa-ami- no-alfa-(p-hidroxifenil) acetamido) - 3 - metil-3-cefem-4- carboxilico. | |
| PT71946A (en) | Process for preparing derivatives of 6beta-hydroxyalkylpenicillanic acids as beta-lactamase inhibitors | |
| SE431986B (sv) | Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-/(z)-2-(fur-2-yl)-2-metoxiiminoacetamido/-cef-3-em-4-karbonsyra | |
| JPS53103493A (en) | Cephalosporin derivatives and process for their preparation | |
| IE45015L (en) | Cephalosporin derivatives. | |
| AU520898B2 (en) | Crystalline sodium salt ofthe oxime derivative of 7-amino thiazolyl acetamido celphalosporanic acid | |
| ES412859A1 (es) | Un procedimiento para la preparacion de un derivado de 7- (alfa hidroxi-alfa-fenil) acetamido - 3 - (1 - metil - 1h - tetrazol - 5 - iltiometil) cefalosporina. | |
| SU671732A3 (ru) | Способ получени кристаллической безводной натриевой соли 7-( -2окси-2-фенилацетамидо)-3-(1-метил1н-тетразол-5-илтиометил)-3-цефем-4-карбоновой кислоты | |
| DE3476663D1 (en) | Crystalline form of ceftazidim | |
| SE8001177L (sv) | Forfarande for framstellning av natriumcefuroxim | |
| FR2279754A1 (fr) | Procede de preparation de derives de l'acide 7-aminocephalosporanique | |
| EP0166580A3 (fr) | Préparation de ceftazidine | |
| ATA387779A (de) | Werkstoff zur pulvermetallurgischen herstellung von gegenstaenden mit hoher verschleissfestigkeit, sowie gegenstand daraus | |
| FR2298552A1 (fr) | Procede de preparation de derives d'acide 7-aminocephalosporanique | |
| GB2012270A (en) | Crystallisation process for sodium cefuroxime | |
| SE432255B (sv) | Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2metoxiiminoacetamido)-cef-3-em-4-karbonsyra | |
| SE7703689L (sv) | Cefalosporiner | |
| NZ194895A (en) | Non-hygroscopic sodium salt of (6r 7r)-3-acetoxymethyl-7-((z)-2(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid and pharmaceutical compositions | |
| BE870861A (fr) | Nouveau derive de la cephalosporine c, procede de preparation et application a la preparation de l'acide 7-amino cephalosporanique | |
| DE3782939D1 (de) | Kristalline cephalosporinderivate. | |
| EP0122584A3 (fr) | Forme cristalline de ceftazidim | |
| ES8305774A1 (es) | Procedimiento para preparar derivados de cefalosporina. | |
| KR920021562A (ko) | 3-피라진 유도체 치환된 세팔로스포린 화합물 |